NFKB1 and laryngotracheoesophageal cleft: Based on the previous hypothesis, ICL can indirectly inhibits NF-κB activity and its leading LC progression by regulating NKRF expression through miR19-3p/NKRF pathway, we further verified the pathway of ICL in C-LCs.